Topical Insulin for Neurotrophic Keratopathy
Author Information
Author(s): Mancini Alessandra, Mancini Maura, Taloni Andrea, Bifezzi Luca, Romeo Maria Angela, Rijillo Lorenzo, Verdiglione Mario, Scorcia Vincenzo, Aragona Pasquale, Giannaccare Giuseppe
Primary Institution: Department of Ophthalmology, University Magna Graecia of Catanzaro, Italy
Hypothesis
Can topical insulin eye drops alone or with a drug-depository contact lens effectively treat refractory neurotrophic keratopathy?
Conclusion
Topical insulin, used alone or with a drug-depository contact lens, is an effective treatment for refractory neurotrophic keratopathy.
Supporting Evidence
- All patients achieved complete healing of corneal epithelial defects.
- No adverse events or episodes of NK recurrence were reported.
- Insulin eye drops were prescribed 4 times a day.
- DDCL was applied in selected patients to enhance treatment efficacy.
- Mean reduction rate of epithelial defect areas was −0.75 mm2/day.
- Patients were followed for at least 3 months after complete healing.
Takeaway
This study shows that using insulin eye drops can help heal a serious eye condition where the cornea doesn't heal properly.
Methodology
This was a multicentric prospective open-label uncontrolled case series involving patients with refractory neurotrophic keratopathy treated with insulin eye drops and, in some cases, a drug-depository contact lens.
Potential Biases
Potential biases due to the uncontrolled nature of the study and the small sample size.
Limitations
The small sample size and variability in patient characteristics may limit the generalizability of the results.
Participant Demographics
8 patients (4 males, 4 females) with a mean age of 52.50 years.
Statistical Information
P-Value
0.71
Confidence Interval
95% CI, 20.30–31.26
Statistical Significance
p=0.71
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website